25 Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Cleantech Solutions International Inc CLNT rose 32.1 percent to $4.32 in pre-market trading as YSK 1860 Co reported a 29.4 percent stake in Cleantech after the close on Monday.
• Recro Pharma Inc REPH rose 13.2 percent to $8.50 in pre-market trading after the company reported successful top-line results from Phase III safety study of IV Meloxicam.
• Valeant Pharmaceuticals Intl Inc VRX shares rose 12.7 percent to $10.94 in pre-market trading after the company posted a profit in its first quarter, versus a year-ago loss. The company also raised its FY17 adjusted EBITDA outlook.
• Camtek LTD. CAMT shares rose 10.7 percent to $4.45 in pre-market trading after reporting upbeat quarterly results.
• Fabrinet FN rose 10.6 percent to $37.60 in pre-market trading. Fabrinet posted downbeat Q3 earnings, but revenue exceeded estimates.
• Nova Measuring Instruments Ltd. NVMI shares rose 10 percent to $21.15 in pre-market trading. Nova Measuring Instruments reported Q1 profit of $13.4 million on revenue of $54.4 million.
• Soligenix, Inc. SNGX rose 9.8 percent to $2.80 in pre-market trading after dropping 7.61 percent on Monday.
• Office Depot Inc ODP shares rose 7.4 percent to $5.49 in pre-market trading after the company reported better-than-expected earnings for its first quarter.
• Gener8 Maritime Inc GNRT rose 6.6 percent to $5.20 in pre-market trading after the company reported strong quarterly results.
• Daqo New Energy Corp DQ rose 6.5 percent to $21.00 in pre-market trading. Daqo New Energy reported Q1 earnings of $22.9 million on revenue of $83.8 million.
• Check Cap Ltd CHEK rose 6.4 percent to $2.10 in pre-market trading. Check-Cap reported Q1 adjusted net loss of $2.4 million.
• Endo International plc ENDP shares rose 5.8 percent to $11.48 in pre-market trading after reporting strong quarterly profit.
• Marriott International Inc MAR shares rose 5 percent to $101.16 in pre-market trading after the company posted stronger-than-expected earnings for its first quarter.
• Five9 Inc FIVN rose 4.7 percent to $21.50 in pre-market trading after slipping 0.19 percent on Monday.
• Pandora Media Inc P rose 3.9 percent to $10.80 in pre-market trading. Pandora posted a narrower-than-expected loss for its first quarter, but issued a weak sales forecast for the current quarter. Pandora announced a $150 million investment by KKR and disclosed that the company is exploring strategic alternatives, including a sale.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Hertz Global Holdings, Inc HTZ shares fell 16.8 percent to $12.40 in the pre-market trading session as the company reported a wider-than-expected loss for its first quarter.
• Nevro Corp NVRO fell around 12.3 percent to $75.70 in pre-market trading as the company posted a larger-than-expected quarterly loss. Riley downgraded Nevro from Buy to Neutral.
• Allot Communications Ltd ALLT shares fell 9.6 percent to $4.44 in pre-market trading after the company posted a wider-than-expected Q1 loss.
• Cytokinetics, Inc. CYTK fell 9.3 percent to $14.20 in pre-market trading. Cytokinetics priced its 5.26 million share offering at $14.25 per share.
• Inpixon INPX fell 7.9 percent to $4.09 in pre-market trading after surging 148.04 percent on Monday.
• Meet Group Inc MEET shares fell 6.5 percent to $5.90 in pre-market trading. Meet Group reported adjusted earnings of $0.07 per share on revenue of $20.1 million.
• Armada Hoffler Properties Inc AHH fell 5.2 percent to $13.06 in pre-market trading. Armada Hoffler Properties priced 6 million shares at $13 per share.
• Preferred Apartment Communities Inc. APTS fell 4.9 percent to $15.10 in pre-market trading. Preferred Apartment Communities reported a proposed public offering of 2.75 million shares of common stock.
• Cytosorbents Corp CTSO fell 4.3 percent to $4.50 in pre-market trading. CytoSorbents reported a Q1 loss of $0.05 per share on revenue of $2.59 million.
• Achaogen Inc AKAO fell 4.2 percent to $22.50 in pre-market trading. Achaogen reported a Q1 loss of $33.3 million.